Seiji Matsumoto1, Tadashi Hanai, Hirotsugu Uemura. 1. Urological and Urodynamic Center, Koushinkai Hospital, Toyoda, Sakai, Osaka, 590-0106, Japan. seiji_matsumoto@e-hainyo.com
Abstract
OBJECTIVES: We have previously shown that a phosphodiesterase 5 (PDE5) inhibitor, vardenafil, possesses bladder protective effects in bladder outlet obstruction (BOO) rats by preserving contractile force. In this study, we examined the effects of vardenafil to obtain clues for further research elucidating the mechanism of action of vardenafil on rat normal bladder. MATERIALS AND METHODS: In all, twenty 12-week-old female Sprague-Dawley rats were divided into two equal groups: group 1, water-treated rats; and group 2, vardenafil-treated rats. Vardenafil (8 mg/kg/day) was given by drinking water. Four weeks after, vardenafil was washed out by giving water for 24-48 h, and then bladder was excised and dissected into four longitudinal strips for isometric organ bath assay. Contractile profile of bladder strips to electrical field stimulation (EFS), carbachol, and potassium chloride (KCl) was investigated. RESULTS: Vardenafil had no effect on body and bladder weight. Contractile forces to EFS, carbachol, and KCl were all increased significantly in group 2 by chronic vardenafil treatment. CONCLUSION: These effects were consistent with those observed in BOO rats for carbachol response, suggesting that effects of vardenafil are not limited to diseased condition, but also apply in normal condition. Chronic treatment with vardenafil increased contractile force of rat normal bladder strips.
OBJECTIVES: We have previously shown that a phosphodiesterase 5 (PDE5) inhibitor, vardenafil, possesses bladder protective effects in bladder outlet obstruction (BOO) rats by preserving contractile force. In this study, we examined the effects of vardenafil to obtain clues for further research elucidating the mechanism of action of vardenafil on rat normal bladder. MATERIALS AND METHODS: In all, twenty 12-week-old female Sprague-Dawley rats were divided into two equal groups: group 1, water-treated rats; and group 2, vardenafil-treated rats. Vardenafil (8 mg/kg/day) was given by drinking water. Four weeks after, vardenafil was washed out by giving water for 24-48 h, and then bladder was excised and dissected into four longitudinal strips for isometric organ bath assay. Contractile profile of bladder strips to electrical field stimulation (EFS), carbachol, and potassium chloride (KCl) was investigated. RESULTS:Vardenafil had no effect on body and bladder weight. Contractile forces to EFS, carbachol, and KCl were all increased significantly in group 2 by chronic vardenafil treatment. CONCLUSION: These effects were consistent with those observed in BOO rats for carbachol response, suggesting that effects of vardenafil are not limited to diseased condition, but also apply in normal condition. Chronic treatment with vardenafil increased contractile force of rat normal bladder strips.
Authors: Kevin T McVary; Claus G Roehrborn; Jed C Kaminetsky; Stephen M Auerbach; Barton Wachs; Jay M Young; Anne Esler; Gregory D Sides; Bela S Denes Journal: J Urol Date: 2007-04 Impact factor: 7.450
Authors: S Oger; D Behr-Roussel; D Gorny; T Lebret; P Validire; X Cathelineau; L Alexandre; F Giuliano Journal: Br J Pharmacol Date: 2010-07 Impact factor: 8.739
Authors: Irina V Zabbarova; Youko Ikeda; Mark G Kozlowski; Pradeep Tyagi; Lori A Birder; Basu Chakrabarty; Subashan Kpg Perera; Rajiv Dhir; Adam C Straub; Peter Sandner; Karl-Erik Andersson; Marcus J Drake; Christopher H Fry; Anthony J Kanai Journal: J Pathol Date: 2022-02-15 Impact factor: 9.883
Authors: Jong Soo Han; Su Jin Kim; Yoonjin Nam; Hak Yeong Lee; Geon Min Kim; Dong Min Kim; Uy Dong Sohn Journal: Biomol Ther (Seoul) Date: 2019-01-01 Impact factor: 4.634
Authors: Jong Soo Han; Young Sil Min; Gil Hyung Kim; Sang-Hyun Chae; Yoonjin Nam; Jaehwi Lee; Seok-Yong Lee; Uy Dong Sohn Journal: Korean J Physiol Pharmacol Date: 2018-08-27 Impact factor: 2.016